Aurora Cannabis Wins Rights for Licensing Talks With CannaRoyalty

The licensing deal would allow Aurora to sell a range of cannabis-infused consumer products.

December 14, 2017

(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.

Aurora—one of the biggest Canadian cannabis companies—has an exclusive right for 90 days to hammer out a licensing agreement that could give it the rights to sell inhalers, transdermal patches, gels and lotions.

RELATED: Canadian Cannabis News

Aurora, which currently only makes medical cannabis, has been seeking deals to offer more products including consumer-oriented products like ones offered by CannaRoyalty, a small Ottawa-based firm.

Trulieve Announces Registration Statement Filing

All 4Front Subsidiaries File for Court-Appointed Receiver

Green Thumb Industries Reports $280M in Q1 Revenue

Tilray Brands Announces Proposed Reverse Stock Split

Trulieve Announces Registration Statement Filing

The cannabis company has no immediate plans to offer or sell any securities under the shelf registration.

Trulieve Resized

All 4Front Subsidiaries File for Court-Appointed Receiver

The company intends to continue operating during the receivership process and hopes the process will generate value for stakeholders.

4 Front Ventures Corp All 4 Front Subsidiaries File For Court App

Green Thumb Industries Reports $280M in Q1 Revenue

The cannabis company also reported $74 million in cash flow from operations and a GAAP net income of $8 million.

Green Thumb Image

Tilray Brands Announces Proposed Reverse Stock Split

The global cannabis company also announced a corresponding special stockholders meeting.

Tilray Brands Reports Quarterly Financial Results, Confirms No Tariff Impacts

The global cannabis company generated a net revenue of $186 million in the third fiscal quarter, verifying it has no current impacts from U.S. tariffs.

SNDL Reports Q4 and Full Year 2024 Financial and Operational Results

The company reported record full-year net revenue, gross profit and gross margin, as well as positive cash flow and free cash flow.

Sndl Inc Sndl Announces Overheads Restructuring Project And Ope

Ascend Wellness Reports $562 Million in 2024 Revenue

The cannabis company also reported its second full year of positive cash from operations and positive free cash flow.

Ascend Cannabis Top

The Cannabist Co. Reports $459 Million in 2024 Revenue

The cannabis company continues to complete divestitures, reduce operating and overhead costs, and refine its inventory assortment.

Green Thumb Industries Announces $50 Million Share Repurchase Program

The program authorizes the cannabis company to repurchase up to nearly 10.6 million subordinate voting shares during the next 12 months.

Adobe Stock

Green Thumb Industries Refinances Senior Debt, Closing on $150 Million Syndicated Credit Facility

The cannabis company intends to use the proceeds along with existing cash to retire its $225 million senior secured debt.

Green Thumb

Ascend Wellness Holdings Removes CEO, Terminates CFO

The cannabis company appointed board Director Samuel Brill to replace John Hartman as CEO. The company also appointed a new president and CFO.

Ascend Wellness Holdings

TerrAscend Offers $10 Million Share Repurchase Program

The company is authorized to repurchase up to 10 million shares but is not obligated to purchase any shares during the 12-month stock buyback program.

Page 1 of 183